CV8 THE COST-EFFECTIVENESS (COST-UTILITY) OF EPROSARTAN IN HYPERTENSIVE PATIENTS WITH CEREBROVASCULAR DISEASE IN BELGIUM, GERMANY, SPAIN, UNITED KINGDOM, AND SWEDEN
B Schwander, P Lindgren, B GradlVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64903-0
File:
PDF, 95 KB
english, 2007